AHA 2015

2015-11-07 - 2015-11-11
Orlando, United States

ESC 2015

2015-08-29 - 2015-09-02
London, United Kingdom

CE Summit 2014

2014-12-06 - 2014-12-07
Ljubljana, Slovenia

AHA 2014

2014-11-15 - 2014-11-19
Chicago, United States

ESC 2014

2014-08-30 - 2014-09-03
Barcelona, Spain
Search in Scientific Content:
Date
Filters:
PROACT: Do
4:30

PROACT: Do ACE Inhibitors Help Prevent Cardiotoxicity in Patients Treated For Breast Cancer or Lymphoma?

Presenter: David Austin
ACC 2024
Lerodalcib
21:56

Lerodalcibep reduces LDL cholesterol by over 50% in high-risk patients

Presenter: Eric Quinton Klug
ACC 2024
Outcomes A
7:49

Outcomes After Technology Assisted Nonprescription Rosuvastatin Administration: The TACTiC Trial

Presenter: Steven E. Nissen
ACC 2024
EMPACT-MI:
8:47

EMPACT-MI: Empagliflozin Post MI Does Not Lower Risk of First HF Hospitalization, Death

Presenter: Javed Butler
ACC 2024
ULTIMATE-D
6:50

ULTIMATE-DAPT: Most Patients With ACS Can Safely Stop Aspirin One Month Post PCI

Presenter: Gregg Stone
ACC 2024
Study Link
2:59

Study Links E-Cigarette Use with Higher Risk of Heart Failure

Presenter: Yakubu Bene-Alhasan
ACC 2024
Percutaneo
5:47

Percutaneous Transvalvular Micro-axial Flow Pump in Infarct Related Cardiogenic Shock

Presenter: Robert Roswell
ACC 2024
Joint Amer
9:47

Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials

Presenter: B. Hadley Wilson
ACC 2024
The import
14:17

The importance of intensive lipid lowering in CV risk reduction: the role of early combination treatment

Presenter: Alberto Zambon
ESC 2023
State of a
10:39

State of art lipid-lowering treatment in 2023

Presenter: Stephen J. Nicholls
ESC 2023
Key points
7:23

Key points from the 2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Presenter: Marco Metra
ESC 2023
Heart Fail
2:32

Heart Failure management in the post-COVID era - Lessons from the pandemic

Presenter: Theresa McDonagh
ESC 2023
Highlights
9:50

Highlights of ESC2023 Congress - Heart failure in focus

Presenter: Carlos Aguiar
ESC 2023
Burden of
6:17

Burden of Cardiovascular Disease in the European Union

Presenter: Panos Vardas
ESC 2023
Prospectiv
2:40

Prospective Meta-Analysis of SGLT2 Inhibitor Randomized Trials in COVID-19

Presenter: Mikhail Kosiborod
ESC 2023
When real-
8:47

When real-world data meet real patients' needs: how to optimally treat patients with chronic coronary syndromes in 2023?

Presenter: Luis Henrique Gowdak
ESC 2023
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients

Presenter: Andreas Goette
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
HOPE 4 - I
5:19

HOPE 4 - Impact on cardiovascular risk of a community based multifaceted intervention in individuals with hypertension in 2 middle income countries: The Heart Outcomes Prevention and Evaluation 4 study

Presenter: J.D. Schwalm
SYNTAXES:
7:28

SYNTAXES: Ten-Year Survival after Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention: The SYNTAX Extended Survival study

Presenter: Daniel Johannes Franciscus Maria Thuijs
MITRA-FR -
8:46

MITRA-FR - 2 years follow-Up of the MITRA-FR study a randomized controlled trial evaluating the effectiveness of percutaneous mitral valve repair in secondary mitral regurgitation

Presenter: Jean-Francois Obadia
DAPA HF Th
6:20

DAPA HF The Dapagliflozin And Prevention Of Adverse-outcomes In Heart Failure Trial

Presenter: John McMurray
CONDI-2/ER
4:010

CONDI-2/ERIC-PPCI Effect of remote ischemic conditioning on clinical outcomes in patients with Stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Presenter: Hans Erik Botker
General as
1:18

General aspects of the ESH2023 Hypertension Guidelines - What are the major changes?

Presenter: Michel Burnier
How shall
1:23

How shall be treat hypertension and look at cardiac risk factors when we consider proper treatment?

Presenter: Konstantinos Tsioufis
The prefer
0:57

The preferred treatment of hypertension with RAAS blockade inhibitors

Presenter: Martin Strauss
What clini
1:16

What clinicians should know about the new ESH guideline regarding hypertension in women?

Presenter: Renata Cifkova
How to man
1:00

How to manage isolated systolic hypertension in the young?

Presenter: Paolo Palatini
Blood pres
1:34

Blood pressure monitoring in general and what we can do to encourage people.

Presenter: Neil Poulter
How to man
1:08

How to manage masked and masked uncontrolled hypertension?

Presenter: Paolo Palatini
Once-weekl
1:17

Once-weekly semaglutide in people with HFpEF and obesity

Presenter: Mikhail Kosiborod
Should ABP
1:31

Should ABPM parameters have a role in clinical practice?

Presenter: Paolo Palatini
On the mos
1:09

On the most important key points on the diagnosis of Hypertension in the new ESH2023 guidelines

Presenter: Bryan Williams
2023 ESC G
1:13

2023 ESC Guidelines for the Management of Endocarditis

Presenter: Michael A. Borger
How to mea
1:37

How to measure blood pressure in the very obese patients?

Presenter: Paolo Palatini
The keypoi
1:14

The keypoints of 2023 ESC Guidelines for the Management of Cardiomyopathies

Presenter: Juan Pablo Kaski
How to bes
1:20

How to best perform office blood pressure management?

Presenter: Paolo Palatini
Key points
1:09

Key points from the newly updated ESC Heart Failure guidelines

Presenter: Marco Metra
Do overwei
0:54

Do overweight and obesity confer an additional risk of CAD in patients with FH?

Presenter: Amany Elshorbagy